Clinical Trial Update: Effect of CT1812 Treatment on Brain Synaptic Density [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on CT1812 shows results for Alzheimer's disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• CT1812

Snippet

Sponsor: Cognition Therapeutics | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-01